Literature DB >> 7685516

Cell-surface expression of immunoglobulin G receptors on the polymorphonuclear leukocytes and monocytes of extremely premature infants.

N R Payne1, J Frestedt, N Hunkeler, R Gehrz.   

Abstract

This study measured Fc gamma receptor (FcR) expression on polymorphonuclear leukocytes (PMN) and monocytes from extremely premature infants. Flow cytometry was used to quantitate FcRIII [cluster of differention (CD) 16], FcRII (CD32), FcRI (CD64), CD14, and CD67 proteins on the PMN surface. Sixty-four premature infants with a mean gestational age +/- SD of 26 +/- 2 wk (birth weight = 847 +/- 217 g), 12 infants born at term (gestational age = 38 +/- 1 wk), and 37 adults were studied. Premature infants' PMN expressed less FcRIII, measured as mean log channel fluorescence (MCF), than did term infants or adults (MCF = 4.7 +/- 1.4, 6.1 +/- 1.0, and 8.8 +/- 1.8, respectively, p < 0.050). Premature infants also had a lower proportion of FcRIII-positive PMN than term infants or adults (mean +/- SEM = 0.83 +/- 0.02 versus 0.92 +/- 0.04 and 0.96 +/- 0.01, respectively, p < 0.050). FcRIII expression on PMN was positively associated with cell isolation procedures (p = 0.004), birth weight (p = 0.004), and postnatal age (p = 0.032). Premature infants also had lower PMN expression of FcRII when compared with adults and term infants (MCF = 2.4 +/- 0.6 versus 3.0 +/- 0.7 and 3.1 +/- 0.3, p < 0.050). Both premature and term infants had fewer FcRII positive PMN than did adults (mean +/- SEM = 0.90 +/- 0.09 and 0.89 +/- 0.07 versus 0.99 +/- 0.00, p < 0.050). Premature infants' monocytes also expressed significantly less FcRIII (MCF = 2.4 +/- 0.6 versus 3.4 +/- 0.9, p = 0.047) and FcRII (2.1 +/- 0.5 versus 2.9 +/- 0.6, p = 0.01) compared with adults. We conclude that extremely premature infants have decreased expression of FcRIII and FcRII on both their PMN and monocytes when compared with adults. The decrease in PMN FcRIII expression appears related to birth weight and chronologic age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685516     DOI: 10.1203/00006450-199305000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants.

Authors:  B Weinberger; D L Laskin; T M Mariano; V R Sunil; C J DeCoste; D E Heck; C R Gardner; J D Laskin
Journal:  J Leukoc Biol       Date:  2001-12       Impact factor: 4.962

2.  Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults.

Authors:  K D Fairchild; R G Hudson; S D Douglas; S E McKenzie; R A Polin
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

3.  Decreased CD47 expression during spontaneous apoptosis targets neutrophils for phagocytosis by monocyte-derived macrophages.

Authors:  Donald W Lawrence; Sarah B King; William A Frazier; Joyce M Koenig
Journal:  Early Hum Dev       Date:  2009-10-07       Impact factor: 2.079

4.  Phagocytic ability of neutrophils and monocytes in neonates.

Authors:  Athanasios Filias; Georgios L Theodorou; Sofia Mouzopoulou; Anastasia A Varvarigou; Stephanos Mantagos; Marina Karakantza
Journal:  BMC Pediatr       Date:  2011-04-14       Impact factor: 2.125

5.  Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2.

Authors:  Megan N Ballinger; Marc Peters-Golden; Bethany B Moore
Journal:  Respir Res       Date:  2011-12-05

Review 6.  Recent Advances in Camel Immunology.

Authors:  Jamal Hussen; Hans-Joachim Schuberth
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

7.  The Impact of Anticoagulation Agent on the Composition and Phenotype of Blood Leukocytes in Dromedary Camels.

Authors:  Jamal Hussen; Turke Shawaf; Sameer M Alhojaily
Journal:  Vet Sci       Date:  2022-02-13

8.  Dengue virus neutralization in cells expressing Fc gamma receptors.

Authors:  Tanu Chawla; Kuan Rong Chan; Summer L Zhang; Hwee Cheng Tan; Angeline P C Lim; Brendon J Hanson; Eng Eong Ooi
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.